Related Experiment Video
Updated: Sep 20, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.4K
The Potential to Leverage Real-World Data for Pediatric Clinical Trials: A Proof-of-Concept Study
Jens Declerck1, Joanne Lee2, Anando Sen2
1The European Institute for Innovation Through Health Data, Ghent, Belgium.
Journal of Medical Internet Research
|May 30, 2025
Summary
Structured pediatric clinical data is scarce in European hospitals, hindering real-world data (RWD) use in research. This study assessed data availability, finding gaps in disease-specific information, which limits its application in clinical trials.
Area of Science:
- Pediatric clinical research
- Real-world data (RWD) utilization
- Electronic Health Records (EHR) data standardization
Background:
- Pediatric clinical research, particularly for rare diseases, faces significant hurdles in patient identification, recruitment, and trial execution due to small, stratified populations and fragmented data.
- Real-world data (RWD) from electronic health records (EHRs) offers potential for innovative trial designs, including real-world comparator arms and postmarketing surveillance.
- The effective use of RWD hinges on the routine availability of structured and reusable clinical data.
Purpose of the Study:
- To evaluate the availability and structure of routine clinical data within European pediatric hospitals.
- To assess data elements relevant for constructing comparator arms and conducting postmarketing surveillance studies.
- To examine data collection practices for neurofibromatosis (NF) and atopic dermatitis (AD) as representative pediatric conditions.
Main Methods:
- Developed an inventory of 113 critical clinical data items based on expert analysis of NF, AD, and safety study protocols.
- Administered a structured web-based survey across European pediatric sites via the connect4children (c4c) National Hub network.
- Assessed data capture methods: structured/coded EHR fields, free text, external systems, or paper records.
Main Results:
- Survey responses from 24 hospitals in 11 European countries indicated substantial variability in data capture and storage.
- General clinical and drug safety data (e.g., demographics, vital signs, medications) were frequently structured.
- Disease-specific and contextual variables, lifestyle, and family history data were often recorded as free text or inconsistently, limiting EHR data reusability for research.
Conclusions:
- Significant gaps exist in the structured documentation of pediatric clinical data across European healthcare settings.
- The lack of standardized, coded data formats impedes the reuse of EHR data for observational studies and comparator arms.
- This proof-of-concept study confirms the feasibility of assessing EHR data availability and provides a foundation for expanding RWD integration in pediatric research.
Related Concept Videos
Clinical Trials
9.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.3K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
184
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
184
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K

